Figure 3B shows that a low ratio (Q1) of FoxP3+/CD45RO+ cells was associated with a longer survival without the need for definitive ADT (log-rank p=0.017) while Figure 3F shows that a high ratio (Q4) of FoxP3+/CD45RO+ cells predicts a shorter time to BCR (log-rank=0.003). At the opposite a low ratio (Q1) of CD45RO+/CD3+ is associated with a shorter BCR-free survival (Figure 3D, log-rank=0.024) while a high ratio (Q4) of CD45RO+/CD3+ cells was associated with a longer lethal PCa-free survival (Figure 3H, log-rank=0.022). The gene discussed is FOXP3; the disease is posterior cortical atrophy.